In 2019, Rodriguez et al. developed a bioprinted MM organoid model using a hydrogel scaffold that combined fibronectin, denatured collagen (Gelin-S), a photo-initiator and a crosslinker, with primary BM aspirates from MM patients (Table 1) [119]. This evidence concerns the gene FN1 and Miyoshi myopathy.